Reaction
Premature Menopause reporting signals
As of the last recalculation, Premature Menopause appears in 914 FAERS reports alongside 21 co-occurring drug terms. The strongest observed disproportionality signal is BUSULFAN (PRR 81.4).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Busulfan | 53 | 81.4 | 81.6 |
| Fludarabine Phosphate | 66 | 41.1 | 41.2 |
| Ifosfamide | 34 | 37.4 | 37.4 |
| Melphalan | 29 | 30.0 | 30.0 |
| Cyclophosphamide Injection, Solution | 184 | 29.4 | 29.4 |
| Cyclophosphamide | 184 | 29.4 | 29.4 |
| Cyclophosphamide For Injection | 184 | 29.4 | 29.4 |
| Melphalan Hydrochloride | 29 | 27.2 | 27.2 |
| Bleomycin Sulfate | 12 | 26.8 | 26.8 |
| Thiotepa | 11 | 26.5 | 26.6 |
| Voriconazole Injection | 17 | 18.1 | 18.2 |
| Terbinafine Hydrochloride | 7 | 18.1 | 18.1 |
| Liothyronine Sodium | 6 | 15.8 | 15.8 |
| Minocycline | 8 | 15.8 | 15.8 |
| Goserelin | 9 | 15.4 | 15.4 |
| Etoposide | 45 | 14.6 | 14.6 |
| Voriconazole | 17 | 13.0 | 13.0 |
| Doxorubicin | 47 | 12.6 | 12.6 |
| Medroxyprogesterone Acetate | 22 | 10.3 | 10.3 |
| Levonorgestrel | 69 | 8.4 | 8.4 |
| Copper | 9 | 4.8 | 4.8 |